Colorado Institute for Drug, Device and Diagnostic Development Awards Funding to Flashback Technologies

The Colorado Institute for Drug, Device and Diagnostic Development (CID4) has selected Longmont, CO-based Flashback Technologies, Inc. to receive funding and management assistance. - August 03, 2011 - Colorado Institute for Drug, Device and Diagnostic Development

Mouse Monoclonal ABCG8 Antibody Announced by Novus Biologicals

Novus Biologicals announced today a new mouse monoclonal ABCG8 antibody. ABCG8 is an ATP binding cassette family member which acts to exclude non-cholesterol sterol entry to the intestine, to promote excretion of cholesterol and sterols into bile, and to facilitate transport of sterols back into... - August 03, 2011 - Novus Biologicals

AbboMax Announces the Availability of New Mouse Anti-Desmoglein 3 (Dsg3) Monoclonal Antibody

Desmogleins are calcium-binding transmembrane glycoproteins, members of the desmosomal cadherins that provide adhesive integrity to desmosomes between adjoining keratinocytes. Desmoglein 3 protein has been identified as the autoantigen of the autoimmune skin blistering disease pemphigus vulgaris and plays important roles in human squamous cell cancer. - August 03, 2011 - AbboMax, Inc.

BioPharm Systems to Present at the 16th Annual Oracle Health Sciences User Group Meeting

Leading IT consulting company focused on the implementation and hosting of clinical trial software will speak at Oracle's annual event. - August 03, 2011 - BioPharm Systems

Novus Biologicals Announces VMAT2 Antibody Made Using SDIX Genomic Antibodies™

Novus Biologicals announced today a new VMAT2 antibody (NBP1-69750) for use in neurotransmission research. This VMAT2 antibody was made using SDIX Genomic Antibody TechnologyTM (GATTM). VMAT2 is a multipass membrane protein responsible for vesicular transport of neurotransmitters by pumping... - August 01, 2011 - Novus Biologicals

New Products Now Available Via the NovaTeinBio Website

Boston based biological reagents provider, NovaTeinBio Inc. has recently announced that they have added new products to their varied catalogue. The new products are an addition to the already outstanding array of solutions that the company offers to their clients across the scientific... - July 31, 2011 - Novatein Biosciences

Tracking Environmental Monitoring Trends Crucial to Regulatory Compliance, OsoBio Expert Says

A microbiology laboratory manager at OSO BioPharmaceuticals Manufacturing, LLC, has authored a chapter on environmental monitoring trends for an industry reference manual. Kim Van Antwerpen wrote a chapter for “Environmental Monitoring: A Comprehensive Handbook (vol. 5)” edited by... - July 30, 2011 - OSO BioPharmaceuticals Manufacturing, LLC

Stevens Professor EH Yang Receives DURIP Grant to Support Nanoscale Imaging

Dr. Yang's AFOSR-sponsored DURIP grant allows him to purchase a scanning probe microscope capable of imaging in ambient conditions. - July 29, 2011 - Stevens Institute of Technology

Dr. Chandramouli of Stevens Gives Keynote on Dynamic Spectrum Access at Wireless Security Conference

Dr. R. Chandramouli of Stevens gave the Wireless Summit track keynote lecture, “Dynamic Spectrum Access Wireless Networking," at the NIKSUN World Wide Security & Mobility Conference 2011 (NIKSUN WWSMC) in Princeton, NJ, on July 27. - July 29, 2011 - Stevens Institute of Technology

Colorado Institute for Drug, Device and Diagnostic Development Sets August 5th as Submission Date for New Project Consideration

The Colorado Institute for Drug, Device and Diagnostic Development (CID4) is seeking its fifth project and a review date of Friday, August 5th has been selected as the cut-off for submitting material to CID4.com for consideration. - July 27, 2011 - Colorado Institute for Drug, Device and Diagnostic Development

Exploring Science Through Underwater Robotics

The Center for Innovation in Engineering and Science Education at Stevens is leading a National Science Foundation initiative to improve K-12 STEM skills and education through fun summer camps and educator institutes. - July 27, 2011 - Stevens Institute of Technology

Raybiotech Launches Risk-Free Trial Program for ELISA Kits

RayBiotech, Inc., has just launched a Risk-Free Trial on its ELISA kits, stipulating that if a researcher is unsatisfied with the performance of any RayBio® ELISA, EIA, or phosphorylation ELISA, they can receive a full product refund or credit. - July 22, 2011 - RayBiotech, Inc

Stevens Students Win 5th in International Autonomous Surface Vehicle Competition

The Stevens team won 5th at the International RoboBoat Competition, held June 9-12 in Virginia Beach. - July 21, 2011 - Stevens Institute of Technology

Valencia Practice Adpots New and Discreet STARR Weight-Loss Treatment

Town Center Surgery’s Dr. Monali Misra praises privacy and comfort of new procedure, no visible scars. - July 21, 2011 - TransEnterix

AnaSpec Releases Anti-LL-37

AnaSpec is pleased to announce the release of a new anti-LL-37. Rabbit Anti-human Cathelicidin LL-37 polyclonal antibody was raised against a synthetic peptide from a sequence found within 134-170 amino acid residues (LL-37) of the LL-37 precursor human cationic antimicrobial protein, hCAP-18... - July 17, 2011 - AnaSpec, EGT Group

AnaSpec Expands SensoLyte® MMP Assay Kits Collection

Since its introduction, AnaSpec, EGT Group’s product line of SensoLyte® 520 MMP Assay Kits has become the new standard in MMP assay sensitivity. These fluorescence resonance energy transfer (FRET)-based assay kits utilizing the 5-FAM/QXL™ 520 are some of the most sensitive and... - July 17, 2011 - AnaSpec, EGT Group

AnaSpec Specializes in Custom Peptide Synthesis

Since 1993, AnaSpec has assisted scientists in the design and synthesis of >50,000 peptides. As a result, AnaSpec's combined knowledge and expertise provide premium solutions to its customers. AnaSpec routinely completes difficult peptide synthesis such as synthesis of long peptides... - July 15, 2011 - AnaSpec, EGT Group

NanoSort, Inc. Awarded NIH “Lab to Marketplace” SBIR Grant to Develop Next-Generation Flow Cytometer and Cell Sorter

The National Institutes of Health awarded technology start-up NanoSort, Inc. a 2 year, $698,000 small business innovation research (SBIR) grant. Granted by NIH’s National Center for Research Resources (NCRR), this SBIR will enable NanoSort to advance their development of next-generation... - July 14, 2011 - NanoSort

Stevens Institute of Technology Hosted Biomaterials Research Conference

The Stevens Conference on Bacteria-Material Interactions was a space for discussing future-oriented strategies critical to developing safer, more effective biomaterials that promote healing while minimizing the risk of infection. - July 09, 2011 - Stevens Institute of Technology

2nd International Conference on Tocotrienols and Chronic Diseases at Wynn Resort, Las Vegas, July 2011

Latest research studies, technical application as well as market potential of palm tocotrienol complex will be shared in this conference. - July 08, 2011 - Carotech Inc.

New Virus Modification Approach to Creating Vaccines for Insect-Borne Diseases

A technology breakthrough that could have a major impact in the development of vaccines to preventive insect-borne diseases has been published in the June edition of Virology Journal, - July 07, 2011 - Arbovax Inc

BioPharm Systems to Present the Top 10 Reasons Why Life Sciences Companies Need a Clinical Trial Management System

The free one-hour webinar will discuss the top ten reasons why it makes sense for organizations to invest in a CTMS. - July 07, 2011 - BioPharm Systems

BioPharm Systems to Host Webinar on Flexible Study Design in Oracle Clinical and Remote Data Capture

The free one-hour webinar will examine the new flexible study design features in the latest version of OC/RDC. - July 07, 2011 - BioPharm Systems

BioPharm Systems to Host Webinar on Using Siebel Clinical for Your Specific Job Function

The free one-hour webinar will explore how Oracle's CTMS can be used by the six most common clinical trial management job functions. - July 07, 2011 - BioPharm Systems

Red Cedar Technology Positions Itself for Rapid Growth

Consistent Performance Relative to Aggressive Growth Plan Leads to Promotions - July 02, 2011 - Red Cedar Technology

Novus Biologicals Announces Opening of Canadian Office

Novus Biologicals, an international supplier of antibodies and antibody-related products to bioscience researchers, is proud to announce the opening of their second international office in Oakville, Ontario, Canada. Novus' other offices include Novus Europe, which services Europe from Cambridge,... - June 30, 2011 - Novus Biologicals

Dr. Masoud Toloue will Describe Methyl-Seq, PCR-Free and Small RNA-Seq NGS Library Prep Technologies

This week at the European Next Generation Sequencing Congress in Hamburg, Germany, Dr. Masoud Toloue of Bioo Scientific will describe the latest improvements in DNA and RNA library prep technologies for NGS. - June 30, 2011 - Bioo Scientific

Colorado BioScience Association Showcases Colorado's Bioscience Industry at BIO 2011 Conference in Washington DC, June 27-30

Colorado BioScience Association (CBSA) will head the Colorado Pavilion at the Biotechnology Industry Organization’s (BIO) International Convention in Washington DC, June 27-30. The Colorado Pavilion, located in booth # 2107 of the Exhibit Hall area, includes a number of companies and partners helping to grow the bioscience industry in the state. - June 29, 2011 - Colorado BioScience Association

Mitegen Awarded $250K NIH STTR Phase II Grant

Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, has been awarded a phase II STTR (small business technology transfer program) award from the NIH (National Institute of Health) for the development of improved crystallization plates. - June 27, 2011 - MiTeGen, LLC

Clinical Trials in Russia. Year 2010.

The Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (Roszdravnadzor) and the Ministry of Health and Social Development of the Russian Federation (MoH) approved 492 new clinical trials of all types including local and bioequivalence studies during 2010, demonstrating a 15% decrease from the last year figure. - June 27, 2011 - Synergy Research Group

Industry Professor Elaine Pratt Named Co-op Advisor of the Year at Stevens

Industry Professor Elaine Pratt has been recognized by the Stevens Institute of Technology Office of Cooperative Education as the 2011 Academic Advisor of the Year for her work with Pharmaceutical Manufacturing graduate students. - June 25, 2011 - Stevens Institute of Technology

OSO BioPharmaceuticals Receives DEA Approval to Handle Controlled Substances

OSO BioPharmaceuticals Manufacturing, LLC, has been granted research and analytical licenses by the U.S. Drug Enforcement Administration (DEA) to handle Schedule II through V controlled substances. - June 24, 2011 - OSO BioPharmaceuticals Manufacturing, LLC

Stevens Selected to Host 2012 IEEE SAM Workshop

Stevens Institute of Technology has recently been announced as host of the IEEE 2012 Sensor Array and Multichannel Signal Processing Workshop (SAM 2012). The biennial SAM Workshop will be held on Stevens campus in Hoboken, New Jersey on June 17-20, 2012. - June 24, 2011 - Stevens Institute of Technology

ALPCO Appoints CST China as Their Exclusive Distributor in China

ALPCO Appoints CST China as Their Exclusive Distributor in China

ALPCO Diagnostics, a leading manufacturer and distributor of high quality immunoassay kits, is pleased to announce that they have appointed CST (Shanghai) Biological Reagents Company Ltd. (CST China) as their new distributor in China. With CST China as their new distribution channel in China,... - June 23, 2011 - ALPCO

AnaSpec Highlights Anb-Wang Resin

Colorimetric based Peptide-p-Nitroanilide conjugates (peptide-pNAs), with absorbance at approximately 408 nm, have historically been and are still widely used substrates for the study of protease activity. However, the preparation of peptide-pNA presents technical challenges. The amino group of pNA... - June 23, 2011 - AnaSpec, EGT Group

Red Cedar Technology Releases New HEEDS Post-Processing Software

Preview version of HEEDS POST 1.0 available now - June 23, 2011 - Red Cedar Technology

AnaSpec Offers Custom Assay Development Service

AnaSpec, EGT Group, provider of the long wavelength, ultra-sensitive SensoLyte® assay kits, is pleased to offer custom service for the development of assays. The long wavelength of SensoLyte® protease assays, many of which utilize the 5-FAM/QXL™ 520 and HiLyte Fluor™... - June 23, 2011 - AnaSpec, EGT Group

Colorado Institute for Drug, Device and Diagnostic Development Awards Funding to Fort Collins-Based VetDC

The Colorado Institute for Drug, Device and Diagnostic Development (CID4) has selected Ft. Collins, Colorado-based VetDC to receive funding and management assistance to advance its Lead Molecule, VDC 1101. VetDC in-licenses, develops and commercializes technologies to address serious unmet medical needs in companion animals. - June 23, 2011 - Colorado Institute for Drug, Device and Diagnostic Development

Dr Joe Krebs Will Lecture About Melamine Detection in Food at the AOAC Pacific NW Annual Meeting

The Director of Protein Chemistry & Engineering at Bioo Scientific, Joe Krebs, will give a lecture describing his research on sequential injection analysis of melamine in food samples at the AOAC Pacific Northwest Section Annual Meeting. - June 22, 2011 - Bioo Scientific

One-Shot Dengue Fever Vaccine Moves Closer to Reality

Arbovax, Inc. is an early stage biotechnology company based in Raleigh NC, developing a novel and innovative technology to facilitate the development of vaccines against insect-borne viruses. Their initial focus, Dengue Fever, is ranked second only to Malaria by the World Health Organization for its devastating global impact. - June 21, 2011 - Arbovax Inc

The International Aging Research Portfolio (IARP) Team Announces the Launch of FundingTrends.org

The development team of the International Aging Research Portfolio (IARP) today announced the launch of the beta version of FundingTrends.org – a simple and effective online tool for comparing funding trends in biomedical research based on keywords and phrases used in successful grant... - June 20, 2011 - The International Aging Research Portfolio

BioPharm Systems to Host Webinar on Oracle Argus Safety and Oracle Argus Safety Japan

Leading provider of Oracle's clinical trial, data, and drug safety solutions will discuss the benefits of Argus Safety and Argus Safety Japan. - June 17, 2011 - BioPharm Systems

Dr. Marahelli G. Prasad of Stevens Receives ASME Award

Dr. Marahelli G. Prasad, Professor of Mechanical Engineering and Director of the Noise and Vibration Control Laboratory at Stevens Institute of Technology, received the 2011 American Society of Mechanical Engineers (ASME) Student Section Advisor Award for District A for his dedicated service as an advisor. - June 15, 2011 - Stevens Institute of Technology

Bioo Scientific Optimizes the Screening of Multiple Tetracycline Residues in Milk, Meat and Honey

Bioo Scientific is working to improve the screening for tetracycline residues in milk, meat, honey and other sample types by improving the MaxSignal® Tetracycline ELISA Kit by offering higher sensitivity and simplified extraction protocols and also by launching kits for the specific detection of oxytetracycline, chlortetracycline and doxycycline residues. - June 13, 2011 - Bioo Scientific

Using Nanosilica to Strengthen Concrete at Stevens Institute of Technology

Jon Belkowitz, a concrete expert and doctoral student at Stevens Institute of Technology, studies chemical reactions within concrete at the nanoscale to formulate a new concrete mixture that will result in longer-lasting buildings, roadways, sidewalks, stairs, sewers, and dams. - June 12, 2011 - Stevens Institute of Technology

Dr. Frank Fisher of Stevens Selected for Fulbright Specialist Roster

Dr. Frank Fisher at Stevens Institute of Technology has recently been added to the Fulbright Specialist Roster for his expertise in engineering education. - June 11, 2011 - Stevens Institute of Technology

Stevens Institute of Technology 2011 Commencement

On May 26th, Stevens Institute of Technology in Hoboken, NJ celebrated the Class of 2011 with Commencement activities on Castle Point. - June 10, 2011 - Stevens Institute of Technology

MoBiTec Expands Its Selection of High Quality Gene Expression Systems for Bacillus megaterium

Based on its already successful protein expression systems for Bacillus megaterium, MoBiTec GmbH introduces a new family of protein expression vectors, the hp-Expression Systems, for high yield expression in the well-established organism Bacillus megaterium. This new system complements the existing non-E. coli expression systems for B. megaterium, Bacillus subtilis, Lactococcus lactis and yeast. Further non-E. coli expression systems are in preparation. - June 09, 2011 - MoBiTec GmbH

Aciont® to Present at the 13th Annual NIH SBIR/STTR Conference

Dr. Kongnara Papangkorn’s presentation is entitled, “Safety Aspects and Drug Delivery Performance of Visulex® Passive Delivery System” - June 09, 2011 - Aciont Inc.

Carotech to Showcase GRAS-Approved Tocomin Palm Tocotrienol Complex at IFT 2011, New Orleans, Louisiana, USA

Carotech will share applications and benefits of TocoBev tocotrienol beverage powder at IFT. - June 09, 2011 - Carotech Inc.

Press Releases 2,001 - 2,050 of 3,226